logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Quidel Corporation


USPTO Granted Patents = 87



Trademarks = 29

Forward Citations = 3,226

Loading Chart...
Loading Chart...

130 inventors (with patents filed for the assignee):

goldMedal Allan D Pronovost (18 out of 28 patents)

silverMedal Hans R Boehringer (12 out of 14 patents)

bronzeMedal Bruce L Jacono (9 out of 9 patents)

4.  Paul Lambotte (8 out of 9 patents)

5.  Jhobe Steadman (7 out of 9 patents)

6.  Jeremy Jerome (7 out of 7 patents)

7.  Mark Daquipa (7 out of 7 patents)

8.  Jason McClure (6 out of 15 patents)

9.  Paul J Lawrence (6 out of 32 patents)

10.  Robert Reed (5 out of 7 patents)

11.  Robert Weiller (5 out of 7 patents)

12.  David Dickson Booker (5 out of 5 patents)

13.  Michael Cerrito (5 out of 6 patents)

14.  Cecille Ramirez (5 out of 6 patents)

15.  Jan W Pawlak (5 out of 5 patents)


Core Competencies:
Autoantibodies Detection
Disease Diagnostics
Immunoassay Devices
Fluid Flow Control
Point-of-Care Testing
Microfluidic Technology
Analyte Isolation
Rapid Diagnostic Assays
Whole Blood Separation
Analytical Devices
Lateral Flow Assays
Reagent Compositions

87 patents:

1. 12174185 - Compositions and methods for detecting autoantibodies (2024-12-24),
2. 12055542 - System and methods for remote assessment of a sample assay for disease diagnostics (2024-08-06),
3. 11953428 - Method for reducing analyzer variability using a normalization target (2024-04-09),
4. 11846637 - Immunoassay test device with two fluid flow paths for detection and differentiation of two or more analytes (2023-12-19),
5. 11783563 - Software and algorithms for use in remote assessment of disease diagnostics (2023-10-10),
6. 11674961 - Extraction reagent for use in an assay for detection of group A (2023-06-13),
7. 11650200 - Device for whole blood separation (2023-05-16),
8. 11560584 - Phage-mediated immunoassay and methods for determining susceptibility of bacteria to antibiotic or probiotic agents (2023-01-24),
9. 11548938 - DbpA antibodies and uses thereof (2023-01-10),
10. 11446654 - Substrate with channels for controlled fluid flow (2022-09-20),
11. 11131670 - Immunoassay test device with two fluid flow paths for detection and differentiation of two or more analytes (2021-09-28),
12. 11131666 - System and apparatus for point-of-care diagnostics (2021-09-28),
13. 11061020 - Interactive test device and apparatus with timing mechanism (2021-07-13),
14. 10908145 - Device for whole blood separation (2021-02-02),
15. 10845300 - Method for reducing analyzer variability using a normalization target (2020-11-24),
Quidel Corporation is a leading diagnostic healthcare manufacturer that delivers rapid diagnostic testing solutions to aid in the detection and management of various diseases. They develop and market a wide range of diagnostic products, including point-of-care tests, molecular diagnostic systems, and immunoassays. Their tests help healthcare professionals make faster and accurate diagnoses, enabling better patient care. With a commitment to innovation and quality, Quidel Corporation's products are widely used in hospitals, clinics, physician offices, pharmacies, and laboratories worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

87 Patents

#72 in San Diego, CA

#978 in California

#4,135 in US

#8,505 in the World

...
San Diego, CA, United States of America

Quidel Corporation

Forward Citations = 3,226

130 inventors:

goldMedal Allan D Pronovost (18 out of 28 patents)

silverMedal Hans R Boehringer (12 out of 14 patents)

bronzeMedal Bruce L Jacono (9 out of 9 patents)

4.  Paul Lambotte (8 out of 9 patents)

5.  Jhobe Steadman (7 out of 9 patents)

Please report any incorrect information to support@idiyas.com
Loading…